Net earnings for the first quarter were $209.6 million, a slight increase over the first period of 2011. Operating cash flow during the first quarter was $207.4 million.
The company reported 1 percent growth in both the American and European markets, along with a 10 percent growth in the Asia Pacific market. Total knee and hip sales each jumped 2 percent to $471 million and $344 million, respectively. The reconstructive market was also up 2 percent to $860 million.
However, the company’s spine business dropped 7 percent to $53 million.
More Articles on Orthopedic Devices:
Johnson & Johnson’s New CEO Speaks of Change
AlloSource Hires Dale Binke as Vice President of Marketing & Sales
LDR Holdings Appoints Robert McNamara CFO
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
